Tag Archives: Dr Oystein Fluge

Update on rituximab

Drs Oystein Fluge and Olav Mella have been given 2 million Norwegian Kroners (approx. £220,000) to help fund a larger multi-centre follow-up study to confirm their findings  that some people with ME had benefited from the immune modulator rituximab. This … Continue reading

Posted in Newyddion | Tagged , , | Comments Off on Update on rituximab